TickerFactsScreenerDevelopers

Viridian Therapeutics, Inc.\DE (VRDN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2013: -$1.17M2014: -$2.21M2015: -$6.90M2016: -$14.76M2017: -$28.17M2018: -$26.84M2019: -$36.06M2020: -$29.78M2021: -$54.58M2022: -$93.84M2023: -$184.17M2024: -$232.32M2025: -$276.39M-$276.39M
2013Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$276.39M-19.0%
2024-$232.32M-26.1%
2023-$184.17M-96.3%
2022-$93.84M-71.9%
2021-$54.58M-83.3%
2020-$29.78M+17.4%
2019-$36.06M-34.3%
2018-$26.84M+4.7%
2017-$28.17M-90.9%
2016-$14.76M-113.9%
2015-$6.90M-211.7%
2014-$2.21M-89.5%
2013-$1.17M—